Basic info
Industry
biotechnology research
Sectors
Biotechnology
autoimmune disease
Life Science
research
biotechnology
immunology
Health Care
cell therapy
T cells
genetic engineering
tolerance
inflammatory disease
immunotherapy
Medical
Date founded
2018
Funding rounds raised
T
Tr1X raised undisclosed on September 14, 2022
Investors: Neva Finventures